Oncoprotein expression and morphological phenotypes of human breast epithelial cells transformed by the c-Ha-ras oncogene

Oncology Reports

Volumn 14, Issue 4, 2005, Pages 885-893

  Calaf, Gloria M ^a,b   Alvarado, M E ^c   Hei, T K ^a  

^a NewYork Presbyterian Hospital   (United States)

^b UNIVERSIDAD DE TARAPACÁ   (Chile)

^c Faculty of Medicine   (Venezuela)

Author keywords

Breast cancer; c Ha ras transfected cell lines; Oncoprotein

Indexed keywords

BENZO[A]PYRENE; CARCINOGEN; KERATIN; ONCOPROTEIN; PROTEIN P21;

ARTICLE; BIOSYNTHESIS; BREAST TUMOR; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELL TRANSFORMATION; CONFOCAL MICROSCOPY; FLUORESCENCE MICROSCOPY; HUMAN; IN VITRO STUDY; METABOLISM; NEOPLASM; ONCOGENE RAS; PATHOLOGY; PHENOTYPE; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL LINE;

BENZO(A)PYRENE; BREAST NEOPLASMS; CARCINOGENS; CELL DIFFERENTIATION; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; GENES, RAS; HUMANS; KERATINS; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; NEOPLASMS; ONCOGENE PROTEINS; PHENOTYPE; PROTO-ONCOGENE PROTEINS P21(RAS);

EID: 33644822144     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.14.4.885     Document Type: Article

References (63)

1. Loeb LA and Christians FC: Multiple mutations in human cancers. Mutat Res 350: 279-286, 1996. (Pubitemid 26072419)
2. Loeb LA: Foundations in cancer research: cancer cells exhibit a mutator phenotype. Adv Cancer Res 72: 25-56, 1998.
3. Tomlinson IP, Novelli MR and Bodmer WF: The mutation rate and cancer. Proc Natl Acad Sci USA 93: 14800-14803, 1996. (Pubitemid 26419049)
4. Simpson AJG: The natural somatic mutation frequency and human carcinogenesis. Adv Cancer Res 71: 209-240, 1997.
5. Bishop JM: Functions and origins of retroviral transforming genes. In: RNA Tumor Viruses. Cold Spring Harbor Laboratory Press, 1984.
6. Boss JL: The ras gene family and human carcinogenesis. Mutat Res 195: 255-271, 1988.
7. Calaf G and Russo J: Transformation of human breast epithelial cells by chemical carcinogens. Carcinogenesis 14: 483-492, 1993. (Pubitemid 23152785)
8. Calaf G and Hei TK: Establishment of a radiation-and estrogen-induced breast cancer. Carcinogenesis 21: 769-776, 2000. (Pubitemid 30214035)
9. Bonfil RD, Reddel RR, Ura H, Reich R, Fridman R, Harris CC and Klein-Szanto JP: Invasive and metastatic potential of a v-Ha-ras transformed human bronchial epithelial cell line. J Natl Cancer Inst 81: 587-594, 1989. (Pubitemid 19104489)
10. Russo J, Calaf G and Russo IH: A critical approach to the malignant transformation of human breast epithelial cells with chemical carcinogens. Crit Rev Oncog 4: 403-417, 1993.
11. Russo J, Calaf G, Sohi N, et al: Critical steps in breast carcinogenesis. Ann NY Acad Sci 698: 1-20, 1993. (Pubitemid 24027621)
12. Milo G and DiPaolo J: Neoplastic transformation of human diploid cells in vitro after chemical carcinogen treatment. Nature 275: 130-132, 1978.
13. Rhim JS: Neoplastic transformation of human epithelial cells in vitro. Anticancer Res 9: 1345-1365, 1989.
14. Rhim JS, Yoo JH, Park JH, Thraves P, Salehi Z and Dritschilo A: Evidence for the multistep nature of in vitro human epithelial cell carcinogenesis. Cancer Res 17: 5653S-5657S, 1990. (Pubitemid 20263260)
15. Basolo F, Elliott J, Tait L, et al: Transformation of human breast epithelial cells by c-Ha-ras oncogene. Mol Carcinog 4: 25-35, 1991.
16. Giunciuglio D, Culty M, Fassina G, et al. Invasive phenotype of MCF10A cells overexpressing c-Ha-ras and c-erbB-2 oncogenes. Int J Cancer 63: 815-822, 1995.
17. Calaf G, Russo J, Tait L, Estrada S and Alvarado ME: Morphological phenotypes in neoplastic progression of human breast epithelial cells. J Submicrosc Cytol Pathol 32: 83-96, 2000.
18. Bravo R, Frank R, Blundell PA and MacDonald-Bravo H: Cyclin/PCNA is the auxiliary protein of DNA polymerase δ. Nature 326: 515-517, 1987. (Pubitemid 17055498)
19. Waseem NH and Lane DP: Monoclonal antibody for the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form. J Cell Sci 96: 121-129, 1990.
20. Woods AL, Hall PA, Shepherd AM, Hanby AM, Wassen NH, Lane DP and Levison DA: The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S+G2+M phase fraction (flow cytometric analysis) and prognosis. Histopathology 19: 21-27, 1991.
21. Hall PA, Levison DA, Woods AL, et al: Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162: 285-294, 1990.
22. Moriki T, Takahashi T, Tanioka F, Yamane T and Hara R: Proliferative activity in breast carcinoma evaluated by BrdU and PCNA. Correlation with the expression of p53, c-erbB-2, estrogen receptor and P-glycoprotein. Pathol Res Pract 11: 1122-1132, 1995. (Pubitemid 26031758)
23. Alexiev BA: Localization of p53 and proliferating cell nuclear antigen in fine-needle aspirates of benign and primary malignant tumors of the human breast: an immunochemical study using supersensitive monoclonal antibodies and the biotin-streptavin-amplified method. Diagn Cytopathol 15: 277-281, 1996.
24. Schechter AL, Hung MC, Vaidyanathan L, et al: The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. Science 229: 976-978, 1985. (Pubitemid 16248489)
25. Mosselman S, Polman J and Djikema R: Erb β: identification and characterization of a novel human estrogen receptor. FEBS Lett 392: 49-53, 1996. (Pubitemid 26268330)
26. Clark GM and McGuire WL: Follow-up study of HER-2/neu amplification in primary breast cancer. Cancer Res 51: 944-948, 1991.
27. Bacus SS, Ruby SG, Weinberg DS, Chin D, Ortiz R and Bacus JW: HER-2/neu oncogene expression and proliferation in breast cancer. Am J Pathol 137: 103-111, 1990. (Pubitemid 20229593)
28. Kerns BJ, Jordan PA, Huper G, Marks JR, Iglehart JD and Layfield LJ: Assessment of c-erbB-2 amplification by immunohistochemistry in paraffin-embedded breast cancer. Mod Pathol 6: 673-678, 1993. (Pubitemid 2014264)
29. Alimandi M, Romano A, Curia MC, et al: Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas. Oncogene 10: 1813-1821, 1995.
30. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A and McGuire WL: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182, 1987. (Pubitemid 17231334)
31. Van de Vijver MJ, Peterse JL, Mooi WJ, et al: Neu-protein over expression in breast cancer: association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer. N Engl J Med 319: 1239-1245, 1988. (Pubitemid 18267063)
32. Paik S, King CR, Simpson S and Lippman ME: Quantification of erbB-2/neu levels in tissues. Methods Enzymol 198: 290-300, 1991.
33. Ceccarelli C, Santini D, Gamberini M, et al: Immunochemical expression of internal and external ErbB-2 domains in invasive breast cancer. Breast Cancer Res Treat 58: 107-114, 1999. (Pubitemid 30032481)
34. Di Fiore PP, Peirce JH, Kraus MH, Segatto O, King R and Aaronson S: erbB-2 is a potent oncogene when over expressed in NIH/3T3 cells. Science 237: 178-182, 1987. (Pubitemid 17095921)
35. Schonborn I, Zschiesche W, Minguillon C, et al: Prognostic value of proliferating cell nuclear antigen and c-erbB-2 compared with conventional histopathological factors in breast cancer. J Cancer Res Clin Oncol 121: 115-122, 1995.
36. Van der Velden LA, Schaafsma HE, Manni JJ, Ramaekers FC and Kuijpers W: Cytokeratin expression in normal and (pre) malignant head and neck epithelia: an overview. Head Neck 15: 133-146, 1993. (Pubitemid 23066892)
37. Marceau N and Loranger A: Cytokeratin expression, fibrillar organization and subtle function in liver cells. Biochem Cell Biol 73: 619-625, 1995.
38. Quillien V, Ramee MP, Bansard JY, et al: Serum and tissue distribution of a fragment of cytokeratin 19 (cyfra 21-1) in lung cancerpatients. Anticancer Res 15: 2857-2863, 1995. (Pubitemid 26098616)
39. Mukhopadhyay T and Roth JA: Functional inactivation of p53 by antisense RNA induces invasive ability of lung carcinoma cells and down-regulates cytokeratin synthesis. Anticancer Res 16: 1683-1689, 1996. (Pubitemid 26270670)
40. Amos H, Leventhal M, Chu L and Karnovsky MJ: Modifications of mammalian cell surfaces induced by sugars: scanning electron microscopy. Cell 7: 97-103, 1976.
41. Gonda MA, Aranson SA, Ellmore NE, Zeve VH and Nagashima K: Ultrastructural studies of surface features of human normal and tumor cells in tissue culture by scanning and transmission electron microscopy. J Natl Cancer Inst 56: 245-263, 1976.
42. Borek C and Fenoglio CM: Scanning electron microscopy of surface features of hamster embryo cells transformed in vitro by X irradiation. Cancer Res 36: 1325-1334, 1976.
43. Vic P, Vignon F, Derocq D and Rochefort H: Effect of estradiol on the ultrastructure of the MCF-7 human breast cancer cells in culture. Cancer Res 42: 667-673, 1982. (Pubitemid 12173611)
44. Rivedal E and Sanner T: Expression of transformed morphology and anchorage independent growth of hamster embryo cells. Carcinogenesis 4: 817-820, 1983. (Pubitemid 13010772)
45. Soule HD, Maloney TM, Wolman SR, et al: Isolation and characterization of a spontaneously immortalized human breast epithelial cell line. MCF-10. Cancer Res 50: 6075-6086, 1990. (Pubitemid 20331424)
46. Tait L, Soule HD and Russo J: Ultrastructural and immunocytochemical characterization of an immortalized human breast epithelial cell line, MCF-10. Cancer Res 50: 6087-6094, 1990. (Pubitemid 20331425)
47. Calaf G, Russo J and Alvarado ME: Morphological phenotypes in neoplastic progression of benz(α) pyrene-treated breast epithelial cells. J Submicrosc Cytol Pathol 32: 535-545, 2000.
48. Spandidos DA and Wilkie NM: Malignant transformation of early passage rodent cells lay a single mutated human oncogene. Nature 310: 469-475, 1984. (Pubitemid 14052408)
49. Calaf G and Hei TK: Oncoprotein expression in human breast epithelial cells transformed by high LET radiation. Int J Radiat Biol 77: 31-40, 2001. (Pubitemid 32096694)
50. McNutt NS, Hershberg RA and Weinstein RS: Further observations on the occurrence of nexuses in benign and malignant human cervical epithelium. J Cell Biol 51: 805-825, 1971.
51. Russo J, Tait L and Russo IH: Morphological expression of cell transformation induced by c-H-Ras oncogene in human breast epithelial cells. J Cell Sci 99: 453-463, 1991. (Pubitemid 21925032)
52. Cabello G, Juarranz A, Botella LM and Calaf GM: Organophosphorous pesticides in breast cancer progression. J Submicrosc Cytol Pathol 35: 1-9, 2003. (Pubitemid 38658264)
53. Zhou H, Calaf GM and Hei TK: Malignant transformation of human bronchial epithelial cells with the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1- (3-pyridyl)-1-butatone. Int J Cancer 106: 821-826, 2003. (Pubitemid 37071659)
54. Zhang PL, Calaf G and Russo J: Allele loss and point mutation in codon 12 and 61 of the c-Ha-ras oncogene in carcinogen-transformed human breast epithelial cells. Mol Carcinog 9: 46-56, 1994. (Pubitemid 24061285)
55. Zhang PL, Chai YL, Ho TY, Calaf G and Russo J: Activation of c-myc, c-neu and int-2 oncogenes in the transformation of human breast epithelial cell line MCF-10F treated with chemical carcinogens in vitro. Int J Oncol 6: 963-968, 1995.
56. Machotka SV, Garrett CT, Schwartz AM and Callahan R: Amplification of the proto-oncogenes int-2, c-erbB-2 and c-myc in human breast cancer. Clin Chim Acta 184: 207-217, 1989.
57. Roy D, Calaf G and Hei TK: Allelic imbalance at 11p15.5-15.4 correlated with c-Ha-ras mutation during radiation-induced neoplastic transformation human breast epithelial cells. Int J Cancer 103: 730-737, 2003. (Pubitemid 36110228)
58. Silen A, Wiklund B, Norlen BJ and Nilsson S: Evaluation of a new tumor marker for cytokeratin 8 and 18 fragments in healthy individuals and prostate cancer. Prostate 24: 326-332, 1994. (Pubitemid 24177844)
59. Silen A, Wiklund B, Andersson EL and Nilsson S: A novel IRMA and ELISA for quantifying cytokeratin 8 and 18 fragments in the sera of healthy individuals and cancer patients. Scand J Clin Lab Invest 55: 153-161, 1995.
60. Paine TM, Fontanini G, Basolo F, Geronimo I, Elliot JW and Russo J: Mutated c-Ha-ras oncogene alters cytokeratin expression in the human breast epithelial cell line MCF-10A. Am J Pathol 140: 1483-1488, 1992.
61. Woelfle U, Sauter G, Santjer S, Brakenhoff R and Pantel K: Down-regulated expression of cytokeratin 18 promotes progression of human breast cancer. Clin Cancer Res 10: 2670-2674, 2004. (Pubitemid 38509140)
62. Patel VW, Heinel LA, Provencio JJ, Vinall PE, Kramer MS and Rosenwasser RH: Validation of image analysis for enzyme histochemical and immunocytochemical staining. Biotech Histochem 77: 213-221, 2002. (Pubitemid 35345464)
63. Oberholzer M, Ostreicher M, Christen H and Bruhlmann M: Methods in quantitative image analysis (Review). Histochem Cell Biol 105: 333-355, 1996. (Pubitemid 26174078)